Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Researchers from Harvard University describe findings in cancer vaccines
September 16th, 2008
Current study results from the report, 'Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries,' have been published. "The risk of dying from cervical cancer is disproportionately borne by women in developing countries. Two new vaccines are highly effective in preventing HPV 16,18 infection, responsible for approximately 70% of cervical cancer, in girls not previously infected," scientists writing in the journal Vaccine report. "The GAVI Alliance (GAVI) provides technical assistance and financial support for immunization in the world's poorest countries. Using population-based and epidemiologic data for 72 GAVI-eligible countries we...
Source: Cancer Weekly (2008-09-16)
|
